The Basics

Introduction


Multiple myeloma is a type of cancer that begins in the body’s blood cells. In 2008, an estimated 19,920 new cases of multiple myeloma will be diagnosed in the United States, according to the American Cancer Society. Most individuals are over 40 years old when diagnosed. Multiple myeloma affects men slightly more often than women.

Multiple myeloma occurs when the bone marrow, the soft spongy material inside bones, begins producing abnormal plasma cells. Healthy plasma cells are blood cells that play an important role in your body’s immune system, which defends it against infection and disease. They produce proteins that target specific germs, bacteria, and other foreign substances that could harm your body or make you sick. People with multiple myeloma have large numbers of abnormal plasma cells in the bone marrow. These cells also produce abnormal proteins.

At first, multiple myeloma may not cause any symptoms. As more and more abnormal plasma cells crowd the bone marrow and spread through the body, symptoms begin to develop. These can range from bone damage and pain to weakness, fatigue, and infection.

Other names for multiple myeloma are plasma cell myeloma, bone marrow cancer, myelomatosis, and Kahler's disease. Although multiple myeloma affects bones and develops within bones, it is not bone cancer because it develops from the blood cells.

Although the exact cause of multiple myeloma is not known, certain risk factors for the disease have been identified. These include increased age, being African-American, and having family members who were diagnosed with multiple myeloma. Frequent exposure to petroleum, pesticides, or other chemicals, or to high amounts of radiation, are other possible risk factors.

This content was last modified on April 04, 2008 .

Latest Multiple Myeloma News

  • April 21, 2008
    Kidney cancer may be linked to multiple myeloma
    NEW YORK (Reuters Health) - For the first time, researchers have evidence of an association between renal cell carcinoma and multiple myeloma, a type of blood cancer, one that "cannot be explained by random incidence alone," they say.
  • April 18, 2008
    Multiple Myeloma Treatment Does Not Affect the Outcome of Stem Cell Transplant
    A recently published study indicates that the type of initial chemotherapy for multiple myeloma has no impact on the outcome of patients who later undergo autologous stem cell transplant. These findings appeared in an early online publication of Bone Marrow Transplantation.
  • April 3, 2008
    Thalidomide victims seek compensation, 50 years on
    LONDON (Reuters) - Half a century after the launch of the notorious morning sickness pill thalidomide, its surviving victims are demanding 4 billion euros ($6.3 billion) in compensation from the German government and the drug's maker.
Select news items provided by Reuters Health
More Cancer News

Privacy Policy reviewed by TRUSTe

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health
Information:
verify here.

Secure transactions for this website use a thawte certificate to ensure secure transmission of your information.